^
Association details:
| Biomarker: | EGFR L858R + EGFR T790M |
|---|---|
| Cancer: | Lung Cancer |
| Drug: | Tagrisso (osimertinib) (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
A patient with a lung adenosquamous carcinoma harboring a de novo T790M mutation and huge nonbacterial vegetative growths successfully treated with osimertinib: A case report
Published date:
05/04/2023
Excerpt:
Rebiopsy revealed she had comutation of de novo EGFR L858R and T790M….After 2 months of osimertinib treatment, her condition improved, with remarkable decreases in tumor sizes seen on chest CT...
DOI:
https://doi.org/10.1111/1759-7714.14896
